Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Democrats
Pharma
Midterm blue wave brings pharma and MFN under new scrutiny
Pharma leaders should prepare for scrutiny as a blue wave of federal legislators attempt to pry open Trump's MFN deals.
Donavyn Coffey
Nov 12, 2026 2:22pm
Biden admin flags 48 meds for IRA price-hike rebates
Dec 15, 2023 10:20am
Republicans must take a stand in light of ongoing drug shortages
Jun 27, 2023 10:15am
Warren calls on the FTC to scrutinize Big Pharma mergers
Jan 30, 2023 9:40am
Pharma could come under more Democrat scrutiny this year: report
Jan 23, 2023 2:27pm
At the end of 2022 pharma’s rep slowly falling, but not sinking
Dec 19, 2022 5:00am